The FDA appointed Patrizia Cavazzoni to the permanent director role of the Center for Biologics Evaluation and Research (CBER).
1 report, 1 independent
Updated Sep 9
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
The FDA appointed Patrizia Cavazzoni to the permanent director role of the Center for Biologics Evaluation and Research (CBER).
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Center for Biologics Evaluation and Research
FDA research center
Nothing else this week.
- FDA